Latest News Archive

Please select Category, Year, and then Month to display items

UFS launches two public health programmes

31 October 2024 | Story André Damons | Photo André Damons

What started seven years ago as a dream, came to fruition in October 2024, when the Faculty of Health Sciences at the University of the Free State (UFS) officially launched two new programmes, the Master of Public Health and PhD Public Health in the Division of Public Health (DPH).

In his welcome address, Prof Gert van Zyl, Dean of the Faculty of Health Sciences, said it is a significant milestone launching these particularly important programmes in the faculty. The launch took place on 24 October 2024 at the James Moroka Building on the Bloemfontein Campus. These programmes are dedicated to recognising and responding to complex national and global public health challenges through high-quality research, teaching and learning, and engaged scholarship.

Prof Bonang Mohale, UFS Chancellor, and Dr BE Mzangwa, Acting Deputy Director General of the Free State Department of Health and CEO of the Universitas Academic Hospital, were also in attendance, while Mr Ramphelane Morewane, Deputy Director General of HIV/AIDS, TB, Maternal and Child Health, in the National Department of Health, delivered a congratulatory message virtually.

Said Prof Van Zyl: “The vision of the public health dream in the faculty started with a small group of us having a discussion on taking public health forward. At that first meeting we already agreed on an action plan. We knew then if we kept true to this dream, we would have success, but this success would not be for us. It would be for the influence of the lives of many postgraduate students that will enrol in the programmes in this division and uplift themselves by getting a quality and relevant qualification. Ready to serve the bigger community.

“For those who are part of the vision of the public health dream, remember the dream and vision, continue with the collaborative efforts and spirit, remain committed to the dream and do everything that is needed to allow it to excel, and never forget the core values we embraced at the beginning when we started this dream,” said Prof Van Zyl.

Addressing public health challenges

Prof Anthea Rhoda, Acting UFS Vice-Chancellor and Principal, said in a video message that the launch marks a significant milestone symbolising the beginning of an academic endeavour aligned with Vision 130, which emphasises academic excellence, quality and impact.

“Today’s launch represents a crucial step in the Faculty of Health Sciences’ commitment to address public health challenges within our communities, nationally, as well as globally. It also represents a crucial step in the University of the Free State’s dedication to tackling public health challenges that are prevalent in our communities.

“The Division of Public Health aspires to be engaging, diversifying public health through innovative, global responsive research. Public health, as is common knowledge, is the study and practice of safeguarding and improving the well-being of individuals and community. It includes the promotion of healthy lifestyles, the prevention of diseases and efforts to control infectious illnesses,” said Prof Rhoda.

She said it should be remembered that public health encompasses more than a simple field of study, it’s a commitment to service, and a promise to make a positive impact in the world. She is confident that this new programme will contribute significantly to the academic prestige of the UFS and will be a source of innovative solutions to the complex health challenges of the times.

Programmes in high demand

According to Prof Joyce Tsoka-Gwegweni, Vice-Dean: Research, Transformation, and Marketing and Head of the DPH, they only enrolled the first cohort of students in the second semester of 2023.

“During that time, we enrolled six Master of Public Health students and 14 PhDs. This year we enrolled 26 students, 13 in each programme. Currently we have 46 students. 19 Masters’ of Public Health and 27 PhD students, of which 90% are black female students. We also have international students from Lesotho, Namibia and Kenya. The quality of our students is very high. They are already working in health-related institutions and most of them are in leadership positions.

“For the coming year, 2025, we have already received 224 applications for the Master of Public Health programme and 30 for the PhD. We can only accommodate 30. Our programmes are already in high demand nationally and on the continent. They address a range of public health topics of national and international importance,” said the Vice-Dean.

Prof Tsoka-Gwegweni said because of the quality of staff and the quality and relevance of the programmes, their multidisciplinary nature, sustainability, and responsiveness to local, national and global public health challenges, these programmes are contributing to the UFS vision of achieving academic excellence, quality and impact; maximum societal impact with sustainable relationships; and of achieving a diverse, inclusive equitable university.

Health and prevention are primary

Prof Geoffrey Setswe, the Managing Director of the Aurum Research Institute, delivered the keynote address, saying public health, unlike medicine and nursing is not about treating individual patients, but focuses on the maintenance of promotion of health at a population level. Health and prevention are primary. He also talked about the public health pathways and career options in this field.

The best-known elements of public health, he said, are health promotion, environmental health, surveillance, communicable disease prevention, communication, health equity, emergency preparedness, harm reduction and home visiting programmes.

“The South African public health system is rebuilding itself and working to enhance health and well-being by implementing the NHI that will enable access to high quality, people-centred and integrated health care for all South Africans. Public health training must have multisectoral applications for public health careers, specialisation and advanced education providing life experiences and related expertise for people with diverse origins and ethical motivations,” he said.

According to Prof Setswe, this model will help in the training of public health professionals to deal with the quadruple burden of communicable diseases (HIV, TB, sepsis), non-communicable diseases (cancers, diabetes, cardiovascular diseases), injuries from crime and violence (including GBV), and mental health (including depression, para-suicide, risk behaviour, harmful substance abuse) and maternal and child health.

Click to view document Click and watch the official launch below:

Prof Bonang Mohale, UFS Chancellor, also attended the launched the new Division of Public Health programmes.

Prof Geoffrey Setswe, the managing director of the Aurum Research Institute delivered the keynote address.

Prof Joyce Tsoka-Gwegweni, Vice-Dean: Research, Transformation, and Marketing and Head of the DPH, gave a short history of the DPH.

News Archive

Research contributes to improving quality of life for cancer patients

2016-11-21

Description: Inorganic Chemistry supervisors Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept